Evidence map›Paper›PMID 37260511›Full record

ArticleNAR genomics and bioinformatics2023

Alternative splicing analysis benchmark with DICAST.

Amit Fenn, Olga Tsoy, Tim Faro, Fanny L M Rößler, Alexander Dietrich, Johannes Kersting, Zakaria Louadi, Chit Tong Lio, Uwe Völker, Jan Baumbach and 2 more

Abstract read
In one paragraph

Article in NAR genomics and bioinformatics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Neurofibromin 1 (International journal of molecular sciences · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Amit FennChair of Experimental Bioinformatics, Technical University of Munich, 85354 Freising, Germany.ORCID https://orcid.org/0000-0003-2203-3922
Olga TsoyInstitute for Computational Systems Biology, University of Hamburg, Notkestrasse 9, 22607 Hamburg, Germany.ORCID https://orcid.org/0000-0002-7592-2080
Tim FaroChair of Experimental Bioinformatics, Technical University of Munich, 85354 Freising, Germany.
Fanny L M RößlerChair of Experimental Bioinformatics, Technical University of Munich, 85354 Freising, Germany.
Alexander DietrichChair of Experimental Bioinformatics, Technical University of Munich, 85354 Freising, Germany.
Johannes KerstingChair of Experimental Bioinformatics, Technical University of Munich, 85354 Freising, Germany.ORCID https://orcid.org/0000-0002-3882-0093
Zakaria LouadiChair of Experimental Bioinformatics, Technical University of Munich, 85354 Freising, Germany.
Chit Tong LioChair of Experimental Bioinformatics, Technical University of Munich, 85354 Freising, Germany.ORCID https://orcid.org/0000-0003-2297-831X
Uwe VölkerInterfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Felix-Hausdorff-Straße 8, D-17475 Greifswald, Germany.ORCID https://orcid.org/0000-0002-5689-3448
Jan BaumbachInstitute for Computational Systems Biology, University of Hamburg, Notkestrasse 9, 22607 Hamburg, Germany.ORCID https://orcid.org/0000-0002-0282-0462
Tim KacprowskiDivision Data Science in Biomedicine, Peter L. Reichertz Institute for Medical Informatics of Technische Universität Braunschweig and Hannover Medical School, Braunschweig, Germany.ORCID https://orcid.org/0000-0002-5393-2413
Markus ListChair of Experimental Bioinformatics, Technical University of Munich, 85354 Freising, Germany.ORCID https://orcid.org/0000-0002-0941-4168

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alternative splicing is a major contributor to transcriptome and proteome diversity in health and disease. A plethora of tools have been developed for studying alternative splicing in RNA-seq data. Previous benchmarks focused on isoform quantification and mapping. They neglected event detection tools, which arguably provide the most detailed insights into the alternative splicing process. DICAST offers a modular and extensible framework for analysing alternative splicing integrating eleven splice-aware mapping and eight event detection tools. We benchmark all tools extensively on simulated as well as whole blood RNA-seq data. STAR and HISAT2 demonstrated the best balance between performance and run time. The performance of event detection tools varies widely with no tool outperforming all others. DICAST allows researchers to employ a consensus approach to consider the most successful tools jointly for robust event detection. Furthermore, we propose the first reporting standard to unify existing formats and to guide future tool development.

Identifiers

PMID37260511
PMCPMC10227362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.